Skip to content

To Evaluate Disease and Treatment Awareness, Self Medication Practices and Drugs Prescribed in Patients of Osteoporosis

Evaluation of Disease and Treatment Awareness, Self Medication Practices and Prescription Patterns in Patients of Osteoporosis Attending a Tertiary Care Hospital: A Cross-sectional, Questionnaire-based Study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/067474
Enrollment
600
Registered
2024-05-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M810- Age-related osteoporosis without current pathological fracture

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Raakhi Tripathi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: attending Endocrinology OPD and Orthopaedic OPD and have already been receiving treatment for at least 1 month with confirmed diagnosis of Osteoporosis with or without comorbidities by treating physician.

Exclusion criteria

Exclusion criteria: 1. Patients not willing to give informed consent 2. Patients admitted in IPD and emergency department 3. Newly diagnosed and treatment naive patients

Design outcomes

Primary

MeasureTime frame
1. The primary variable is percentage of patients stating yes for each item of the Disease and Treatment awareness questionnaire. 2. Mean awareness score will be calculated 3. Mean Awareness Score will be correlated with demographic factors (Age, gender, occupation, education, and socio-economic status as per Kuppuswamy scale).Timepoint: As this is a cross-sectional survey, outcomes will be assessed at end of study,i.e, 18 months.

Secondary

MeasureTime frame
Percentage of patients of Osteoporosis with or without comorbidities stating yes for each item of the self medication practice questionnaire using descriptive statisticsTimepoint: As this is a cross-sectional survey, outcomes will be assessed at end of study,i.e, 18 months.;To study the pattern of drugs used in the treatment of Osteoporosis .Timepoint: As this is a cross-sectional survey, outcomes will be assessed at end of study,i.e, 18 months.

Countries

India

Contacts

Public ContactDr Raakhi K Tripathi

Seth GS Medical College and KEM Hospital

urjita28@hotmail.com9769745159

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026